The Hunger Game : The Inside Story of Glp-1s and the Race to Cure Obesity
local_shippingShip to Me
Overview
Revised and updated: the fascinating story of the creation of GLP-1s and their revolutionary impact on public health.
A "cure" for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that activates a hormone in the stomach called GLP-1, making people feel fuller for longer. The treatment is so effective that it is already disrupting many industries--from healthcare to fast food to fashion--and it has quickly made its creator, Denmark's Novo Nordisk, the most valuable company in Europe. But the impact of GLP-1s goes far beyond billion-dollar profits; a true long-term cure for obesity could save 40 percent of American adults from dangerous, preventable illnesses. And as more potential benefits emerge, one question looms in the minds of investors, healthcare workers, and politicians: Are these drugs too good to be true?
Customers Also Bought
Details
- ISBN-13: 9781250389084
- ISBN-10: 1250389089
- Publisher: St. Martin's Griffin
- Publish Date: January 2027
- Dimensions: 8.25 x 5.38 x 1 inches
- Shipping Weight: 1 pounds
- Page Count: 336
Related Categories
